Product Information

BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0860 per ML under NDC 75907020704. Its NADAC has been published 95 times since Jan 22, 2025.

FDA first approved this application on Dec 4, 2018. Its Orange Book therapeutic-equivalence code is AA.

Strength

2; 10; 30 mg/5mL; mg/5mL; mg/5mL

NDC

75907020704

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207676

FDA Approved

12/4/2018

TE Code

AA

On Market Since

9/30/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 95 times since Jan 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0860 per ML
All-time high$0.0869 (May 14, 2025)
All-time low$0.0744 (May 20, 2026)
52-week high$0.0868
52-week low$0.0744
Median price$0.0809
Average price$0.0813
Largest weekly change-7.6% (Dec 17, 2025)
Weeks tracked95
Tracking sinceJan 22, 2025

Price History

1W

0.0%

1M

+5.1%

3M

+7.0%

6M

+15.6%

1Y

-0.9%

3Y

N/A

5Y

N/A

All

-0.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Dr. Reddy's Laboratories Inc., is $0.0860 per ML (NDC 75907020704), effective Nov 11, 2026.

How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?

Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has held within roughly two percent of its current level. It has been tracked across 95 weekly CMS publications since Jan 22, 2025.

What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Since Jan 22, 2025, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0744 (May 20, 2026) to a high of $0.0869 (May 14, 2025), with a median of $0.0809 per ML.

Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMPHEN-PSE-DM 2-30-10 MG/5 ML, is $0.0707 per ML — about 18% below BROMPHEN-PSE-DM 2-30-10 MG/5 ML.

Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 75907020704) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.